GlaxoSmithKline plc (GSK) has formed a new collaboration with the São Paulo Research Foundation (FAPESP), one of the major funding agencies for scientific research in Brazil, to create a new Centre of Excellence for Sustainable Chemistry in Brazil. The Centre will be located in the state of São Paulo and will focus on sustainable chemistries most relevant to the discovery and development of medicines.
The agreement was signed after a meeting with Rogerio Ribeiro, senior vice president, Emerging Markets & Asia Pacific, GSK and Geraldo Alckmin, governor of São Paulo State and Celso Lafer, president of FAFESP.
Rogerio Ribeiro, senior vice president, Emerging Markets & Asia Pacific, GSK said: "GSK has a vibrant and growing business in Brazil and, as part of our continued investment in science in Brazil, we are delighted to announce our support for the new sustainable chemistry centre. This will be an important enabler towards our goal of reducing the environmental impact of both the discovery and subsequent manufacturing of drugs to help us meet our target of being carbon neutral by 2050."
GSK has agreed in principle to co-fund the centre with FAPESP, investing approximately £400,000 per year during a ten-year collaboration which will be matched by FAPESP.
GSK is already supporting a Centre of Excellence for Sustainable Chemistry in the UK based at The University of Nottingham. Once the new centre in São Paulo is established, it will form scientific links with GSK and The University of Nottingham to facilitate the sharing of knowledge and expertise between Brazilian and UK researchers.
Celso Lafer, president of FAPESP said: “FAPESP has formed partnerships to create world class research centres, such as this new collaboration with GSK. By applying interdisciplinary approaches to complex scientific challenges through this collaboration with GSK, FAPESP contributes to a knowledge advance in sustainable chemistry and the development of applications in areas of common interest."
Professor Chris Moody, Sir Jesse Boot Professor at the University of Nottingham, said: “We are delighted to extend our collaboration with GSK into this new venture in Brazil. The Nottingham Centre of Excellence for Sustainable Chemistry that will be housed in a unique Carbon Neutral Building now being built on our Jubilee Campus, will be ideally placed to run a wide range of collaborative projects. We are looking forward to working with Brazilian colleagues.”
This latest announcement builds on GSK’s existing partnership with FAPESP to build a sustainable, long-term scientific research presence in Brazil. Through its ‘Trust in Science’ programme, GSK aims to support outstanding scientific groups in Latin America to validate and explore compelling ideas to treat priority diseases, including those that have a substantial impact on the health of Latin America.
GSK is committed to improving the quality of human life by enabling people to do more, feel better and live longer.